Eltrombopag Clinical Trials
6 recruitingDrug
Phase 23Not Applicable2Phase 41
Showing 1–6 of 6 trials
Recruiting
Phase 2
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
MyelofibrosisSplenomegaly
M.D. Anderson Cancer Center30 enrolled1 locationNCT06345495
Recruiting
Phase 2
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI)80 enrolled1 locationNCT04304820
Recruiting
Not Applicable
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
ITP - Immune Thrombocytopenia
Sohag University100 enrolled1 locationNCT07093606
Recruiting
Phase 4
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Hematological Neoplasms
Wei Zhao1,500 enrolled2 locationsNCT03844360
Recruiting
Phase 2
Eltrombopag for Chemotherapy-induced Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT04600960
Recruiting
Not Applicable
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Immune Thrombocytopenia With Positive ANA Antibodies
Yunfeng Cheng126 enrolled7 locationsNCT06479291